rs80358035

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007294.4(BRCA1):​c.4987-20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000474 in 1,584,512 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0026 ( 2 hom., cov: 30)
Exomes 𝑓: 0.00025 ( 3 hom. )

Consequence

BRCA1
NM_007294.4 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:20

Conservation

PhyloP100: -0.112

Publications

4 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-43067715-T-C is Benign according to our data. Variant chr17-43067715-T-C is described in ClinVar as Benign. ClinVar VariationId is 91635.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00257 (391/152196) while in subpopulation AFR AF = 0.00903 (375/41522). AF 95% confidence interval is 0.00828. There are 2 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.4987-20A>G
intron
N/ANP_009225.1P38398-1
BRCA1
NM_001407581.1
c.5053-20A>G
intron
N/ANP_001394510.1A0A2R8Y7V5
BRCA1
NM_001407582.1
c.5053-20A>G
intron
N/ANP_001394511.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.4987-20A>G
intron
N/AENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.5050-20A>G
intron
N/AENSP00000418960.2P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.4987-20A>G
intron
N/AENSP00000419274.2P38398-1

Frequencies

GnomAD3 genomes
AF:
0.00257
AC:
391
AN:
152078
Hom.:
2
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00906
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000586
AC:
147
AN:
250980
AF XY:
0.000376
show subpopulations
Gnomad AFR exome
AF:
0.00808
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000251
AC:
360
AN:
1432316
Hom.:
3
Cov.:
27
AF XY:
0.000188
AC XY:
134
AN XY:
714220
show subpopulations
African (AFR)
AF:
0.00890
AC:
292
AN:
32794
American (AMR)
AF:
0.000381
AC:
17
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25956
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39524
South Asian (SAS)
AF:
0.0000234
AC:
2
AN:
85618
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53286
Middle Eastern (MID)
AF:
0.000358
AC:
2
AN:
5584
European-Non Finnish (NFE)
AF:
0.00000184
AC:
2
AN:
1085448
Other (OTH)
AF:
0.000757
AC:
45
AN:
59438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00257
AC:
391
AN:
152196
Hom.:
2
Cov.:
30
AF XY:
0.00215
AC XY:
160
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.00903
AC:
375
AN:
41522
American (AMR)
AF:
0.000654
AC:
10
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000996
Hom.:
1
Bravo
AF:
0.00254
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
1
5
Breast-ovarian cancer, familial, susceptibility to, 1 (6)
-
-
3
Hereditary breast ovarian cancer syndrome (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Familial cancer of breast (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
9.6
DANN
Benign
0.73
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80358035; hg19: chr17-41219732; COSMIC: COSV100523982; API